Noninvasive positive-pressure ventilation and ventilator-associated pneumonia

Area of Science:

• Critical Care Medicine
• Respiratory Medicine
• Infectious Disease Epidemiology

Background:

• Noninvasive positive-pressure ventilation (NPPV) is increasingly used to avoid endotracheal intubation and improve patient survival.
• The incidence of pneumonia, particularly ventilator-associated pneumonia (VAP), is a significant concern in mechanically ventilated patients.
• Existing literature presents varied findings on the impact of NPPV on pneumonia rates.

Purpose of the Study:

• To systematically evaluate the risk of pneumonia in patients receiving NPPV.
• To compare pneumonia rates between NPPV and invasive mechanical ventilation (IMV).
• To assess the benefit of NPPV in reducing pneumonia in various clinical scenarios.

Main Methods:

• A meta-analysis was conducted, synthesizing data from 12 studies.
• Studies compared NPPV with IMV or standard therapy.
• Pneumonia rates and relative risks (RR) with 95% confidence intervals (CI) were calculated.

Main Results:

• NPPV showed a significantly lower pneumonia rate compared to IMV (RR 0.15, CI 0.04-0.58).
• Even when accounting for patients who eventually required intubation, NPPV demonstrated a benefit (RR 0.24, CI 0.08-0.73).
• A meta-analysis of all 12 studies revealed a strong overall benefit for NPPV in decreasing pneumonia risk (RR 0.31, CI 0.16-0.57).

Conclusions:

• NPPV is associated with a reduced risk of pneumonia compared to invasive ventilation.
• The evidence supports the use of NPPV or CPAP in appropriate candidates to lower pneumonia incidence.
• Consideration of 'endotracheal-tube-associated pneumonia' may be more precise than 'ventilator-associated pneumonia'.